Literature DB >> 24076652

Usp16: key controller of stem cells in Down syndrome.

Jin-chong Xu1, Valina L Dawson, Ted M Dawson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24076652      PMCID： PMC3817468          DOI： 10.1038/emboj.2013.220

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  10 in total

Review 1.  Cellular ageing of Alzheimer's disease and Down syndrome cells in culture.

Authors:  G Carmeliet; G David; J J Cassiman
Journal:  Mutat Res       Date:  1991 Mar-Nov       Impact factor: 2.433

2.  Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects.

Authors:  Masayuki Kimura; Xiaojian Cao; Joan Skurnick; Michael Cody; Patricia Soteropoulos; Abraham Aviv
Journal:  Free Radic Biol Med       Date:  2005-04-08       Impact factor: 7.376

3.  Defective hematopoietic stem cell and lymphoid progenitor development in the Ts65Dn mouse model of Down syndrome: potential role of oxidative stress.

Authors:  Laureanne Pilar E Lorenzo; Haiyan Chen; Kristen E Shatynski; Sarah Clark; Rong Yuan; David E Harrison; Paul J Yarowsky; Mark S Williams
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

Review 4.  Mechanisms of stem cell self-renewal.

Authors:  Shenghui He; Daisuke Nakada; Sean J Morrison
Journal:  Annu Rev Cell Dev Biol       Date:  2009       Impact factor: 13.827

5.  Regulation of cell cycle progression and gene expression by H2A deubiquitination.

Authors:  Heui-Yun Joo; Ling Zhai; Chunying Yang; Shuyi Nie; Hediye Erdjument-Bromage; Paul Tempst; Chenbei Chang; Hengbin Wang
Journal:  Nature       Date:  2007-10-03       Impact factor: 49.962

6.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus.

Authors:  J J Jacobs; K Kieboom; S Marino; R A DePinho; M van Lohuizen
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

7.  Understanding the basis for Down syndrome phenotypes.

Authors:  Randall J Roper; Roger H Reeves
Journal:  PLoS Genet       Date:  2006-03       Impact factor: 5.917

8.  Usp16 contributes to somatic stem-cell defects in Down's syndrome.

Authors:  Maddalena Adorno; Shaheen Sikandar; Siddhartha S Mitra; Angera Kuo; Benedetta Nicolis Di Robilant; Veronica Haro-Acosta; Youcef Ouadah; Marco Quarta; Jacqueline Rodriguez; Dalong Qian; Vadiyala M Reddy; Samuel Cheshier; Craig C Garner; Michael F Clarke
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

Review 9.  The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome.

Authors:  André Mégarbané; Aimé Ravel; Clotilde Mircher; Franck Sturtz; Yann Grattau; Marie-Odile Rethoré; Jean-Maurice Delabar; William C Mobley
Journal:  Genet Med       Date:  2009-09       Impact factor: 8.822

10.  The many faces of ubiquitinated histone H2A: insights from the DUBs.

Authors:  Joseph Ha Vissers; Francesco Nicassio; Maarten van Lohuizen; Pier Paolo Di Fiore; Elisabetta Citterio
Journal:  Cell Div       Date:  2008-04-22       Impact factor: 5.130
  10 in total
  5 in total

1.  USP16-mediated histone H2A lysine-119 deubiquitination during oocyte maturation is a prerequisite for zygotic genome activation.

Authors:  Yan Rong; Ye-Zhang Zhu; Jia-Li Yu; Yun-Wen Wu; Shu-Yan Ji; Yong Zhou; Yu Jiang; Jin Jin; Heng-Yu Fan; Li Shen; Qian-Qian Sha
Journal:  Nucleic Acids Res       Date:  2022-06-10       Impact factor: 19.160

2.  An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome.

Authors:  Faycal Guedj; Jeroen LA Pennings; Lauren J Massingham; Heather C Wick; Ashley E Siegel; Umadevi Tantravahi; Diana W Bianchi
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

Review 3.  Deubiquitylating enzymes and drug discovery: emerging opportunities.

Authors:  Jeanine A Harrigan; Xavier Jacq; Niall M Martin; Stephen P Jackson
Journal:  Nat Rev Drug Discov       Date:  2017-09-29       Impact factor: 84.694

4.  Increased levels of plasma total tau in adult Down syndrome.

Authors:  Takashi Kasai; Harutsugu Tatebe; Masaki Kondo; Ryotaro Ishii; Takuma Ohmichi; Wing Tung Esther Yeung; Masafumi Morimoto; Tomohiro Chiyonobu; Naoto Terada; David Allsop; Masanori Nakagawa; Toshiki Mizuno; Takahiko Tokuda
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

Review 5.  The role of deubiquitinating enzymes in gastric cancer.

Authors:  Jiangang Sun; Xiaojing Shi; M A A Mamun; Yongshun Gao
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.